ROIVANT SCIENCES

roivant-sciences-logo

Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates. Roivantโ€™s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. Roivant does this by building Vants - nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying the technology. In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines.

#People #Financial #Event #Website #More

ROIVANT SCIENCES

Social Links:

Industry:
Biopharma Biotechnology Health Care Pharmaceutical Product Research

Founded:
2014-05-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.roivant.com

Total Employee:
501+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
2.09 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag Nginx Amazon



Current Advisors List

james-momtazee_image

James Momtazee Board of Director @ Roivant Sciences
Board_member
2021-10-01

Current Employees Featured

vivek-ramaswamy_image

Vivek Ramaswamy
Vivek Ramaswamy Founder and Executive Chairman @ Roivant Sciences
Founder and Executive Chairman
2014-01-01

mayukh-sukhatme_image

Mayukh Sukhatme
Mayukh Sukhatme Chief Investment Officer & President @ Roivant Sciences
Chief Investment Officer & President
2015-01-01

benjamin-zimmer_image

Benjamin Zimmer
Benjamin Zimmer President, Roivant Health @ Roivant Sciences
President, Roivant Health

frank-torti_image

Frank Torti
Frank Torti Vant Chair @ Roivant Sciences
Vant Chair
2018-01-01

matthew-gline_image

Matthew Gline
Matthew Gline Chief Executive Officer @ Roivant Sciences
Chief Executive Officer
2021-01-01

dan-rothman_image

Dan Rothman
Dan Rothman Chief Information Officer @ Roivant Sciences
Chief Information Officer
2017-04-01

not_available_image

Celine Chan
Celine Chan Chief Information Security Officer @ Roivant Sciences
Chief Information Security Officer
2022-04-01

eric-venker_image

Eric Venker
Eric Venker Chief Operating Officer @ Roivant Sciences
Chief Operating Officer
2018-01-01

drew-fromkin_image

Drew Fromkin
Drew Fromkin Chief Executive Officer Proteovant, Vant Portfolio Operating Partner (Roivant Sciences) @ Roivant Sciences
Chief Executive Officer Proteovant, Vant Portfolio Operating Partner (Roivant Sciences)
2021-01-01

raheleh-hatami_image

Raheleh Hatami
Raheleh Hatami Associate, Investments @ Roivant Sciences
Associate, Investments
2018-04-01

Founder


vivek-ramaswamy_image

Vivek Ramaswamy

Stock Details


Company's stock symbol is NASDAQ:ROIV

Acquisitions List

Date Company Article Price
2021-02-26 Silicon Therapeutics Silicon Therapeutics acquired by Roivant Sciences 450 M USD

Investors List

eventide-asset-management_image

Eventide

Eventide investment in Post-IPO Equity - Roivant Sciences

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Post-IPO Equity - Roivant Sciences

viking-global-investors_image

Viking Global Investors

Viking Global Investors investment in Post-IPO Equity - Roivant Sciences

rtw-investments-llc_image

RTW Investments LLC

RTW Investments LLC investment in Post-IPO Equity - Roivant Sciences

patient-square-capital_image

Patient Square Capital

Patient Square Capital investment in Post-IPO Equity - Roivant Sciences

palantir-technologies_image

Palantir Technologies

Palantir Technologies investment in Post-IPO Equity - Roivant Sciences

dainippon-sumitomo_image

Dainippon Sumitomo Pharma

Dainippon Sumitomo Pharma investment in Post-IPO Equity - Roivant Sciences

suvretta-capital-management_image

Suvretta Capital Management

Suvretta Capital Management investment in Post-IPO Equity - Roivant Sciences

softbank-capital_image

SoftBank Capital

SoftBank Capital investment in Post-IPO Equity - Roivant Sciences

novaquest-capital-management_image

Novaquest Capital Management

Novaquest Capital Management investment in Private Equity Round - Roivant Sciences

Investments List

Date Company Article Money raised
2021-11-03 Medallion Roivant Sciences investment in Series B - Medallion 30 M USD
2021-11-01 gen-t Roivant Sciences investment in Pre Seed Round - gen-t 2 M USD
2021-08-02 Immunovant Roivant Sciences investment in Post-IPO Equity - Immunovant 200 M USD
2020-10-08 Datavant Roivant Sciences investment in Series B - Datavant 40 M USD
2018-04-30 Datavant Roivant Sciences investment in Venture Round - Datavant 40.5 M USD
2017-10-02 Arbutus Biopharma Roivant Sciences investment in Post-IPO Equity - Arbutus Biopharma 116.4 M USD

Official Site Inspections

http://www.roivant.com Semrush global rank: 836.93 K Semrush visits lastest month: 45.72 K

  • Host name: 23.185.0.4
  • IP address: 23.185.0.4
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Roivant Sciences" on Search Engine